ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000610.1|Nosiheptide_1 # 1 # 978 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.665	BGC0000610.1|Nosiheptide_1 	1	978	-	Loose	400	172.17	tetB(P)	34.84	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGCTACCACTTCGCTTGACCTGGCCAAGGTGCGCAACATCGGCATCATGGCCCACATCGACGCGGGCAAGACGACCACCACCGAGCGGATCCTGTTCTACACCGGTGTGTCCTACAAGATCGGTGAGGTCCACGACGGCGCTGCCACCATGGACTGGATGGAGCAGGAGCAGGAGCGTGGCATCACGATCACCTCTGCTGCCACCACCTGTCACTGGTCGCTGGACGACGTCGACCACACCATCAACATCATCGACACGCCGGGTCACGTCGACTTCACCGTCGAGGTGGAGCGTTCCCTGCGCGTGCTCGACGGTGCCGTGACGGTGTTCGACGGCGTCGCCGGCGTCGAGCCGCAGTCCGAGACGGTGTGGCGTCAGGCGGACCGCTACGGCGTTCCGCGTATCTGCTTCGTCAACAAGCTCGACCGCACCGGTGCCGAGTTCCACCGCTGTGTCGACATGATCAGCGACCGGCTGGGTGCCCAGCCGATCGTGATGCAGCTGCCGATCGGCGCTGAGGCCGACTTCAAGGGCGTCGTGGACCTGGTCCGCATGAAGGCGCTCGTGTGGTCCGCCGAGGCGACCAAGGGCGAGATGTACGACGTCGTCGACATCCCGGCCACGCACACCGAGGCCGCCGAGGAGTGGCGCGGCAAGCTGCTCGAGGCCGTCGCCGAGAACGACGAAGAGATCATGGAGCTGTACCTGGAGGGCGAGGAGCCCTCCGAGGAGCAGCTGTACGCGGCCATCCGCCGTATCACGATCGCTTCCGGCAAGGGCCAGGGCACCACGGTGACCCCGGTCTTCTGCGGCACCGCGTTCAAGAACAAGGGCGTCCAGCCCCTGCTCGACGCGGTCGTGCGCTACCTGCCCTCCCCGGTCGACATCGAGGCCATCGAGGGCCACGCGGTCGACAACGCCGAAGAGGTCATCAAGCGCAAGCCGTCCGACGAGGAGCCCCTCGCGGCGCTGGCG	MATTSLDLAKVRNIGIMAHIDAGKTTTTERILFYTGVSYKIGEVHDGAATMDWMEQEQERGITITSAATTCHWSLDDVDHTINIIDTPGHVDFTVEVERSLRVLDGAVTVFDGVAGVEPQSETVWRQADRYGVPRICFVNKLDRTGAEFHRCVDMISDRLGAQPIVMQLPIGAEADFKGVVDLVRMKALVWSAEATKGEMYDVVDIPATHTEAAEEWRGKLLEAVAENDEEIMELYLEGEEPSEEQLYAAIRRITIASGKGQGTTVTPVFCGTAFKNKGVQPLLDAVVRYLPSPVDIEAIEGHAVDNAEEVIKRKPSDEEPLAALA	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	50.00	gnl|BL_ORD_ID|737|hsp_num:0	804			0	741	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000610.1|Nosiheptide_2 # 1018 # 1488 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.667	BGC0000610.1|Nosiheptide_2 	1018	1488	-	Loose	500	24.2534	OXA-616	21.57	3005837	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCTCGTAAGGGCCCCGCCCCGAAGCGCCCGGTCATCATCGACCCGGTCTACGGTTCTCCTCTGGTGACCTCCCTGATCAACAAGGTGCTGCTGAACGGCAAGCGCTCCACCGCCGAGCGCATCGTCTACGGCGCCATGGAGGGCCTGCGCGAGAAGACCGGCAACGACCCGGTCATCACGCTCAAGCGCGCTCTCGAGAACATCAAGCCGACCCTCGAGGTCAAGTCCCGCCGTGTCGGTGGCGCCACCTACCAGGTCCCGGTCGAGGTCAAGCCCGGCCGTGCCAACACCCTGGCGCTGCGCTGGCTCGTCGGTTACTCCCGCGCCCGTCGCGAGAAGACCATGACCGAGCGTCTGCTCAACGAGCTCCTCGACGCCTCCAACGGCCTCGGCGCCGCGGTGAAGAAGCGCGAGGACACGCACAAGATGGCCGAGTCCAACAAGGCCTTCGCGCACTACCGCTGGTAG	MPRKGPAPKRPVIIDPVYGSPLVTSLINKVLLNGKRSTAERIVYGAMEGLREKTGNDPVITLKRALENIKPTLEVKSRRVGGATYQVPVEVKPGRANTLALRWLVGYSRARREKTMTERLLNELLDASNGLGAAVKKREDTHKMAESNKAFAHYRW	MRNFIVFIMFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYVKTGFNDSINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELLEKYLAIITN	62.65	gnl|BL_ORD_ID|3872|hsp_num:0	4942			516	651	cloxacillin; oxacillin; cefalotin
BGC0000610.1|Nosiheptide_3 # 1491 # 1862 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=CGGAG;rbs_spacer=5bp;gc_cont=0.640	BGC0000610.1|Nosiheptide_3 	1491	1862	-	Loose	550	25.7942	APH(2'')-Ig	34.78	3002669	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	GTGCCTACGATCCAGCAGCTGGTCCGCAAGGGCCGGCAGGACAAGGTCGAGAAGAACAAGACGCCCGCACTCGAGGGTTCCCCTCAGCGTCGTGGCGTCTGCACGCGTGTGTTCACGACCACCCCGAAGAAGCCGAACTCGGCCCTGCGTAAGGTCGCGCGTGTGCGTCTGACCAGCGGGATCGAGGTCACCGCTTACATTCCGGGTGAGGGACACAACCTGCAGGAGCACTCCATCGTGCTCGTGCGCGGCGGCCGTGTGAAGGACCTGCCGGGTGTTCGCTACAAGATCATCCGTGGCTCGCTCGACACCCAGGGTGTCAAGAACCGCAAGCAGGCCCGCAGCCGCTACGGCGCCAAGAAGGAGAAGTAA	MPTIQQLVRKGRQDKVEKNKTPALEGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLTSGIEVTAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEK	MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDMAIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYEHIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDDFGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAIDPDAFIL	40.20	gnl|BL_ORD_ID|831|hsp_num:0	903			255	324	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000610.1|Nosiheptide_4 # 2249 # 2704 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=CGG;rbs_spacer=7bp;gc_cont=0.748	BGC0000610.1|Nosiheptide_4 	2249	2704	-	Loose	550	24.6386	LRA-7	31.25	3002486	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGACCGAACACCCCGCACAGCAGCTGTACTGCACGGTCGTCCTGTGGGACCTGTCCCGCTCCGCGGCGACCGTCGCCTCCCTGCGCGCCTACCTGCGCGACCACGCCGTGGACGCGTACACGACCGTGCCCGGCCTGCGGCAGAAGACGTGGATCTCCTCCACCGGCCCCGAGGGCGAGCAGTGGGGCGCGGTCTACCTCTGGGACTCGCCCGAGGCCGCCTACGGCCGCCCGCCCGGCGTGTCCAAGGTCGTGGAGCTGATCGGCTACCGCCCGACCGAGCGCCGCTACTACAGCGTCGAGGCCGCCACCGAGGGCCCCGCCGCTGCCGCCGCACCCTTCGGCAAGGGGCTGGGCCTGGCCTTCGACCCGGCCTCGCCCGAGCCGCTGACCCGCCCGCAGGAGTTCGTACCGCCGGGCGCCGACGCCTTCATCCCCTCCCGGCCGCCGGCGTAG	MTEHPAQQLYCTVVLWDLSRSAATVASLRAYLRDHAVDAYTTVPGLRQKTWISSTGPEGEQWGAVYLWDSPEAAYGRPPGVSKVVELIGYRPTERRYYSVEAATEGPAAAAAPFGKGLGLAFDPASPEPLTRPQEFVPPGADAFIPSRPPA	MRSKFLLATALVLSTAFTADAADAPKRLPVNITNQDWLKPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVADMASFKKDAPSAVVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFQFQQTDAGKTYNVMIVNMNGINAGVKLLGSPKYPTIVEDFKNTIDMQATYKPDIWVSSHAGQFNLHQVYKPGDAYNPARFGDQAAYQQKIATAKANYEKQLAEERAAAK	50.00	gnl|BL_ORD_ID|1916|hsp_num:0	2121			381	522	
BGC0000610.1|Nosiheptide_5 # 2701 # 4068 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.767	BGC0000610.1|Nosiheptide_5 	2701	4068	-	Loose	700	27.335	vanS gene in vanA cluster	30.91	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGACGAGAGCCCGACGTACCCCTTCGAGCAGAAGTGCCCCTTCGCCCCACCCGATGAACTGGTCCGCCGCCGCGACGAGGCCCCCGTCTCACAGATCCGCCTCGCGAACGGCGCCACGGCCTGGCTGGTCACCCGCCACGACGACGTCCGCACGGTCCTGACCGACCCCCGCTTCAGCCGCGCGGCGATCCGAGCGGGAGCCCTCCGGGGCGGCCCGCCCGGCCCGGGCGGCCCGGGCGGCTCCGCCGAGGGTGCCCCGCAGGGCGGTTGGCCGGGCGGCCCCGGCGGCTCCGCCGGGGGTGCACCGCAGGGTGGTTGGCCGGGTGGGGTGCCCGGGCCTGGCGGCCCGGGCGGAGCCAGTGTGGGCCCGGGTGCCCCCGGTAAGGGGCCCGGGCAGCGGTTCGACTTCGGGATGGCGCTGGCCGACCCCGAGCGGCACGCCCGGTGGCGCCGTACCCTCGCCACCGTCCTCACCCCCCGGCACGCCGAGTCGCTGCGCAAGGCGGTCGGGCAGGCGGTGGACGAGGTGCTGGACGGGCTCGCCGAGGCGGGGCCGGACCCCGTCGACCTGGTCTCCGGCTTCGCCTACCAGGTGCCCGTCCGCGTGCTGTGCGAGCTGTTCGACCTGCCCGAAGAGCTGCGCCCCGGGCTGTGGGGGTGGGCGGCCCAGGTGCGGGCCGCCGCCCCGTCGACCGCCGCCTTCGGCGCGGCCATGGGCGCGCTGTTCGGCGTGGCCCGGCAGCTGGTGGAGAAGGAGCTGGCCGCTCCCGGCGACGGGCTGATCGGCAGCCTGATCGCGGGCCTCGACGAGGACGCCCGCCCCTCCGCCGACGAACTCGTCTCCACCGTCGTCCTGCTGGCCACCGCCGGCTACGAGTCCACCGCCGTCCAGTTCGCCAACGGACTCCTCGCCCTCTTCCAGCACCCCGACCAGCTCGCCCGGCTGCGCGACGGCACCGTCACCGAGGCCGCCGCCGTCGAGGAGATCCTGCGGTACGCCCAGGCCGGCACCGGCTTCGCCGGGACGACCGTCACCACCGAGGAGGTGACCCTCGGCGGCATCACCCTCCCCGAGGGCGCCACGGTCTTCATCTCCCTCGACTCCGCCGCCCGCGACGAGCGGCACGTCGACCGCCCCGACACCTTCGACCTGGCCCGGGGCGCCGCGCGCACCCACCTCACCTTCGGCGCCGGCGCGCACTACTGCCTCGGCTCGTCCCTCGCCCGCGTGGAACTCCAGGAGGGCTTCGGCCGGCTGCTGCGCCGCTTCCCCGCCCTCACCCCGGCCGCCGACCCGGCCGCCGTGGAGTTCACCGCGAACCTCTTCCACCGGTACCCGCGCGAACTGAAGGCGGTCCTGCGATGA	MDESPTYPFEQKCPFAPPDELVRRRDEAPVSQIRLANGATAWLVTRHDDVRTVLTDPRFSRAAIRAGALRGGPPGPGGPGGSAEGAPQGGWPGGPGGSAGGAPQGGWPGGVPGPGGPGGASVGPGAPGKGPGQRFDFGMALADPERHARWRRTLATVLTPRHAESLRKAVGQAVDEVLDGLAEAGPDPVDLVSGFAYQVPVRVLCELFDLPEELRPGLWGWAAQVRAAAPSTAAFGAAMGALFGVARQLVEKELAAPGDGLIGSLIAGLDEDARPSADELVSTVVLLATAGYESTAVQFANGLLALFQHPDQLARLRDGTVTEAAAVEEILRYAQAGTGFAGTTVTTEEVTLGGITLPEGATVFISLDSAARDERHVDRPDTFDLARGAARTHLTFGAGAHYCLGSSLARVELQEGFGRLLRRFPALTPAADPAAVEFTANLFHRYPRELKAVLR	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	118.49	gnl|BL_ORD_ID|1809|hsp_num:0	1907			801	966	vancomycin; teicoplanin
BGC0000610.1|Nosiheptide_6 # 4083 # 5309 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.713	BGC0000610.1|Nosiheptide_6 	4083	5309	-	Loose	400	25.409	PEDO-3	26.15	3003715	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 PEDO beta-lactamase	GTGGACATCGAAGCGCGCACCTACCCCTTCACCCGCCACACCCCGTTCGAGATGCCGGAGGAGTTCGCCTGGCTGCGCGAGAACCGGCCCATCGCCCAGGTCCGCCTCGCCACCGGCGACACCGCCTGGCTGATCACCCGCTACGAGGACGTCCGCACCGCCCTCACCGACCCGCGGTTCTCCCGCACCATCAACCGGGAGGGCGCGGCCCGGGTGGACACCGGCTTCCAGGCCGACGCCGACAGCCCCGTCTTCAACTTCGGCGGCTCCATCTCCGAACCGCCCGGCCACACCCGCTGGCGCCGCCTGGTCAACCAGGCGTTCACCGCCCGCCACGCCGAGTCGATGCGGCCCGCCGTCGCCGCCCACACCGACGCCCTCCTCGACGACCTCGAAAGCGCCGGCGGTCGCTTCGACCTCATGGCCGACTACGCCTACCAGCTGCCGATCCGGGTCATCTGCGACCTGCTCGGACTGGAGCAGACCGCCCGCCCCGAGTTCTCCGCGCTCGCCGCGCAGATCACCCGCCGCGACTTCACCTCGTCGTTCGTCGAGTTCGGCCAGGCCCTCCAGGCGATCGGCCGGTACGCCATCGGGCTGATCGTCCGCAAGCGGCAGAACCTGGGCGACGACCTGCTCAGCACGCTGATCGGCCTCACCGACGAGGAGGACGGCCGGCTCAGCAACGAGGAACTGGTCTCCACGGTCATCCTGCTGCTGATGGCCGGCTACGAGAGCACCGCCGTCCAGCTCGGCAACGCCTTCTACGCCCTGTTCCGCGACCCCTCCCAGATGCGCCGGCTGCGCGAGGAGCCCGCGCTGATCGGCCAGGCCGTCGAGGAGATCCTGCGGTACGCCCAGATGGGCACCGGGTACGCCATCGCCAAGTTCACCACCGAGGACGTCGAGCTGTCCGGCGGGACCGTCCCGGCCGGCTCGACCGTCTTCGTCTCCCTCGCGTCGGCCAACCGGGACGAGAAGGTCTTCGGCGAGGACGCCGACCGCTTCGACGTCGGCCGCGGCTGCGCCCACCGGCAGACCGCGTTCGGCTACGGCCCCCACTACTGCCTGGGCGCCGCGCTGGCCCGCGTCGAGATGCAGGAGGGCATCGCGCGCATGCTGAACCGCTTCCCGGACCTGCGGTTCGACGGGCCCGACCTGGACGGCGTGCCGCTCGCCAGCAACCTGTTCACCTTCTATCCGGCCGAGCTGCCGGTGCGGATCTGA	MDIEARTYPFTRHTPFEMPEEFAWLRENRPIAQVRLATGDTAWLITRYEDVRTALTDPRFSRTINREGAARVDTGFQADADSPVFNFGGSISEPPGHTRWRRLVNQAFTARHAESMRPAVAAHTDALLDDLESAGGRFDLMADYAYQLPIRVICDLLGLEQTARPEFSALAAQITRRDFTSSFVEFGQALQAIGRYAIGLIVRKRQNLGDDLLSTLIGLTDEEDGRLSNEELVSTVILLLMAGYESTAVQLGNAFYALFRDPSQMRRLREEPALIGQAVEEILRYAQMGTGYAIAKFTTEDVELSGGTVPAGSTVFVSLASANRDEKVFGEDADRFDVGRGCAHRQTAFGYGPHYCLGAALARVEMQEGIARMLNRFPDLRFDGPDLDGVPLASNLFTFYPAELPVRI	MRYLLSFLLCLSAFASFAQNPKIKIKHLTGDLYVYTTYNTYKGALTDANAVYLVTNKGVVVIDAPWDATQFQPFLDSIQTKHHQKVVLAIATHSHGDRAGGLAFFKSKGIKTYTNKLTDEILKTNKEPRAAYTFTNDTTFTVGQYKINTYYAGKGHTKDNLVVWFPKDKVLFGGCLIKSIEANDLGYIGESDLAAWPKSIEKLKQKYPDTKIVITGHAAWGNRESLDHTLKLLREKK	172.15	gnl|BL_ORD_ID|2027|hsp_num:0	2230			39	228	
BGC0000610.1|Nosiheptide_7 # 5328 # 6365 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=CGGAG;rbs_spacer=7bp;gc_cont=0.768	BGC0000610.1|Nosiheptide_7 	5328	6365	-	Loose	2000	27.335	adeB	33.33	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGCCCCTGAGACCGGCCCCTGGCACAGCCTGCACCTGCACCGGTACGCCGGGCAGGACGCGTTCCTCGTGGACGGGCTGGCCCCCGTGCTCGCCCCGCTGCACGCCTCCGGCGCGCTGGAGAGCTCCTTCTTCCTGCGGTACTGGCAGGGCGGCCACCACATCCGGCTCCGCCTGCGCCCCGCCGCCCACGACCCCGAGCAGGCCGCCCGCACCGTGCGCGAGGTCGCCGACCGCCTCGCCGGCCACCTCGCCGCCCATCCCGGCGGCTACGGAGACCTCGACCCCGAGGAGTTCCGCGAGGCCCAGCTGACCATGGCCGCACTGGAGTCGGAGGCGACCGGCGAACTGCTCCCGCCGGACACCGTGCACCCCGCCCGCTACGAGCCCGAGTACGGCAAGTACGGCGGCCCGGAGGGTGTCGCCGTCGCCGAGCGGTTCTTCGACCGCAGCAGCGCCGTCGCCCTGTCCGCGCTGCGCGCCATCGGCGACCGCCCGGCCCGCCGGCTGGGCGCCGCGTTCACCATGACGCTGCGCGGCCTGTGCGCGGCCCGGCTCTCGCCGCCCGCCATGGCCGGGTTCCTCGCCCACTACTGCGCGGTGTGGTCGCCGTACGTCTTCGACAGCTTCCTCGACACCTGGCCCGAGCTGCTGGACCAGCGCCGCGGCCCGGCCGCCGCCCACCTGCGGCCGCTGCTCGCCGCCGCGCAGCCGCCCGACGACCCCTACGGCCGGGCCGTCGGCGAGGCCTGGCAGGCGCTGCACACGGCCGCGGACACCGTGCTGCCCGCGGTCACGCTCGGCGGCCCCGACGCGCCGGCGGAGCGGCGCCGCCAGATCGTGCTCCTCAGCTATCTGCACACCCACAACAACCGGCTGGGCCTCATCCCGGAGCAGGAGGCCTTCCTCGGCTACCTCGGCCACCACGTCGTCGCCGACTGCGCGGGCCTCGCCCCGGACGCCGGCCTGCTCGACCGGGTCCGCGACCACCGCCGGGAACGCCTCGCCGCCCATCTGCCCTCCGGCCAGCACTGA	MPAPETGPWHSLHLHRYAGQDAFLVDGLAPVLAPLHASGALESSFFLRYWQGGHHIRLRLRPAAHDPEQAARTVREVADRLAGHLAAHPGGYGDLDPEEFREAQLTMAALESEATGELLPPDTVHPARYEPEYGKYGGPEGVAVAERFFDRSSAVALSALRAIGDRPARRLGAAFTMTLRGLCAARLSPPAMAGFLAHYCAVWSPYVFDSFLDTWPELLDQRRGPAAAHLRPLLAAAQPPDDPYGRAVGEAWQALHTAADTVLPAVTLGGPDAPAERRRQIVLLSYLHTHNNRLGLIPEQEAFLGYLGHHVVADCAGLAPDAGLLDRVRDHRRERLAAHLPSGQH	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	33.33	gnl|BL_ORD_ID|800|hsp_num:0	866			1050	1176	tigecycline; tetracycline
BGC0000610.1|Nosiheptide_8 # 6352 # 9132 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=CGG;rbs_spacer=10bp;gc_cont=0.763	BGC0000610.1|Nosiheptide_8 	6352	9132	-	Loose	600	28.1054	TLA-1	37.04	3003202	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	GTGAACGACACGACCCGGGTGCCCGGCGCGCCCGACGCTGCCGGCGCGCCCGACGGGTTCAGCCCCTACTACCTCTACCGCCGCGGCACGCTCGGCCCGTCCGAGCTGGCCGCGCTGACCCCGGCGCGCACCTGGGCGCTGCTCGCGGAGGCCGAGGAGACCCGGCAGCGGCGGGAGGAGCTGCGCGGGCGCCTGGAGGACGCGCTGCACGCGGCCGTGCCGGAGCTGCCCGCCGACCGGCGCCACGAACTGCTGCGGCTGCGGCGCGACATCCACAACGACCGCGTCCCCGGCGTCCCCGACGCCGCCCGCCTGCTCGACCCGGCGAGCCGGGAACTGCTGGAGGACTGGCTGCGGCACCGCGCCGAGGGCAACCGGCTGCACAAGGAGGCCGAAGCGGCCCTCGCCGCCGAACTCGACGCGGGTCGAAGGGCGTTGGCGGCCATCGCGACGGGGGAGTTCTTCCAGCGCGGCCTCCAGCTATCCGACGAGCGGACCTGGCGGACCGTCACCGAGTGGGCCGCCGACCCGTTCTCCGCGCGCCGCAAGCCCAGCAAGCGGCGCCGCGCCGAGAACACGCTGACCAGCTTCGCCTACCGGGTCGCCCTCAAGCCGTCGCCGTTCGCCTCCTTCACCGAGATCGGCGCCGCCCCCTGGACGCCCGCCGGCGACGGCACGGCACCGGCCGACCGCCCTCCGGCCCGCCCCGTCCAGGCCCGGCTCAGCGCGGGACTGCTGTCCTGGATGACGTACGAACTGCACCGCCTGGACCGCGCCGACGAGCTGATGCGGATCCGGCTCAACCACTCCCTGCTCGTCCGGGAGGAACAGGCCCTGTGCGTACGGCGGGCCCCGGACGGCGCCCCCGAGGCGGCCTACGGCACCGCCCAGGTGGTGACCGCCCGCGACACCGGCCTGCTGCGCCTGCTGCGGTCCCTGCTCGCCGACGGCGGGCTGCCCGAGCGCGAGCTGCGCGAGAGGCTGGCCGCCGCCGGACTCTCCCCGCAGGCCGCGGCGACCGCCCTGGACAAGCTGGTCCGCGCCGGGATCTGCGAACGCGGGCTCGGCATCCCCGACCAGCACCCGCGCCCCGCGCTCGCCGTCGCCCAGCGGCTGCGCACCCTCGACACCGACCAGGCCGGCCGCTGCGCCGTCGTCTTCGAACGGCTCCAGGCCGCCGAGGACGCCTTCCCGGCCGCCCCCGTGCGGCGGCGGGCCGCGCTGCTGGCCGAGATCCGCGAACAGGTCGCCGTGTTCGTCGAGGCCGTCGGCTGCCGCGCCCCCGCCCCCGAGGCCATGCGCTCCGTCGTCTACGAGGACGTCGGCACCCGCGAACCCGCCCACAGCTGGCACCCGGACCTGCTGCACGCCAACCGCTGGGCCCTGGAGCTGTTCCAGCGGATCGTCCCGGTGCTGGACGACGCGAGCGTGGAGAAGGCGGGCCTGTATGCCTTCTTCGCCCGGCACTTCGGCGCGGCGGACGGCGACGGCGACGTCCCGTTCATCGAGTTCTACCGCCGGTTCGCCGCGCTGCCGCCCGCCGAGGCCAGTGCCGTGGCCTCCGGCGTCGGCGACCCGCACAGCGACCGCATCCGCCGGCTGCGCGCCGACTTCGCCGACCTCCTCCGCACCGAACTGCGCGCCCATGACAGCGCACACACCGGCGCGCTGCGCCTGGACGCCGAGCGGCTGCGCGCCTTCGCCGACCGGCTGCCCGCCGAGGTGACCCCCTGGCGGTCCACCGCCTACCGGATGCAGTTCACCGCGGAACCCGAGCGGCCGTACGCCGTCGTCAACGGCGTCACCACCGGGCACGGCGTGTTCTTCTCCCGGTTCTGCGACCTGCTGGAGCCGGACGGGCCGCACGAGTGGAGCCTCACCGAGGCGCTGCGCGGCCACATCGCCCGCACGACGCCCCGCCAGTGCGACATCACGGCCGTCCTCGGCCTCAACTTCAACCTGCACCCCCGGCTCAGCCCGTACGAGCTGGTCTACCCCGGCTCGGTGCCGCGCGCCGCCGACGAGCACACCCTGACCCTCGCCGACCTGGCCGTCCGCGCCGACCCGGCCCGCCGCACCCTGGCCCTGGTCAGCACCCGCGACGGGCAGCCCCTGGACCTCGTACCGCTCAACTTCCTCTACCCGGCCGCCGCACCCGGCCTGTACCGGCTGCTGTGCGCCTTCGCCCCCACCCGCACCTACCGCGGCGGACTGTGGGACCAGCTCGACCGGGCCGACGCGGAAGCGGGCCGGGCCGCCGGCCGCACCGGCGTCCCCGCCACCCACCGGTCGCTGCCCCGGGTACTGCTCGGCGACCTCGTCCTCGACCGGGCCTCCTGGCGGCTGCCCGCGGCGGACGTCCCGGACACCGACGGCCTGGAACGGCAGGAGGCGGCGGCCCTCGCCTCGTTCGACCGCTGGCTCGGGCAGCGCGGCATCCCCCGGCACACCTTCTTCCGGCTGACCACGCCCCCGCCCGTGCCCGCCGGCGAGCGCGACCTGCTGGCGGAGACCCGGCAGTGGGCGCTGGAGGCGCGCACCGCCCGGCTGCACAAACCGCACTACCTCGACGCCCGCAACCCCTTCCTCCTCCAGGTCTTCGCCCGCCGGCTCGCCGAGGCCGGCCCGGACGCCACCGTCACCTTCCAGGAGTGCCTGCCGCACGCCGGCGACCTGGACGGCCGGACCTCCGGCGCGGAGGAGTTCTTCGTCGAGTACACCCTCGGCACCCCCGCCCCCGCCGGAACCCAGGCCACGGAGGACGCCCATGCCCGCCCCTGA	MNDTTRVPGAPDAAGAPDGFSPYYLYRRGTLGPSELAALTPARTWALLAEAEETRQRREELRGRLEDALHAAVPELPADRRHELLRLRRDIHNDRVPGVPDAARLLDPASRELLEDWLRHRAEGNRLHKEAEAALAAELDAGRRALAAIATGEFFQRGLQLSDERTWRTVTEWAADPFSARRKPSKRRRAENTLTSFAYRVALKPSPFASFTEIGAAPWTPAGDGTAPADRPPARPVQARLSAGLLSWMTYELHRLDRADELMRIRLNHSLLVREEQALCVRRAPDGAPEAAYGTAQVVTARDTGLLRLLRSLLADGGLPERELRERLAAAGLSPQAAATALDKLVRAGICERGLGIPDQHPRPALAVAQRLRTLDTDQAGRCAVVFERLQAAEDAFPAAPVRRRAALLAEIREQVAVFVEAVGCRAPAPEAMRSVVYEDVGTREPAHSWHPDLLHANRWALELFQRIVPVLDDASVEKAGLYAFFARHFGAADGDGDVPFIEFYRRFAALPPAEASAVASGVGDPHSDRIRRLRADFADLLRTELRAHDSAHTGALRLDAERLRAFADRLPAEVTPWRSTAYRMQFTAEPERPYAVVNGVTTGHGVFFSRFCDLLEPDGPHEWSLTEALRGHIARTTPRQCDITAVLGLNFNLHPRLSPYELVYPGSVPRAADEHTLTLADLAVRADPARRTLALVSTRDGQPLDLVPLNFLYPAAAPGLYRLLCAFAPTRTYRGGLWDQLDRADAEAGRAAGRTGVPATHRSLPRVLLGDLVLDRASWRLPAADVPDTDGLERQEAAALASFDRWLGQRGIPRHTFFRLTTPPPVPAGERDLLAETRQWALEARTARLHKPHYLDARNPFLLQVFARRLAEAGPDATVTFQECLPHAGDLDGRTSGAEEFFVEYTLGTPAPAGTQATEDAHARP	MTVPISIIFWGNIMKKHLVVIAFCVLFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAVLGIEDNFKLNVNEKHHYPMQSTYKFHLALAVLDKLDKENISIDKKLFVKKSELLPNTWSPLRDKYPDGNVDLSISEILKATVSRSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYTNWTTPDATVQLLKKFYKNEILSKNSYDYLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSSDTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLVKDGK	294.90	gnl|BL_ORD_ID|497|hsp_num:0	546			375	456	
BGC0000610.1|Nosiheptide_9 # 9129 # 10784 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.791	BGC0000610.1|Nosiheptide_9 	9129	10784	-	Loose	550	26.9498	KPC-61	25.68	3006190	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGACCATGACGACCGACGAGGCGTACACCTACACCACCGGGCTGCGGCTCGACCCGCGCTCCGCCAACCCGGACGGCTGGCGGGTGGACTGGGCCGACGGGCCCTGGCCGGTGAAGGTCTACAGCGGAGCGCGGCGGCTGCCGCTGCGGCCCGACGGACCGCCGCCGCTCGCGGCCCTGCACCGGCTCCTGCACGGCGGCTTCGCCGTCAGCCGGATCCGCACCGACCCGTCCGGCGGCATCGCCGCCACCCCGGCCGACCCGCGTCCGCACCACGGGCCCGAGGTGCAGTTGCGCCGGCCCGTCCCGTCGGGCGGGGCGATGTACCCGACCGAGGTGTACGCCGCCCTCACCGCGACCGGGCAGGTCTGCCACTACGACCCCTACCGGCACGAGCTGACCGTGCTGGCCGGCGGCGACGCGGCGGCCCGGCTGCGCGCCGCGCTGCACCTGCCGACGGAGGCGGCGCCCGCGGCGGTGCTCGTCCTGACCAGCCGCTTCTGGAAGAACTTCTACAAGTACGGCGACTTCGCGACCCGCCTCGGCCTGGTCGACGCCGGGGTCGCCCTCGGCCGCGCCGCCCGCCTCGCGCGGGCCGAGTGGGAGCACGCGGAGGTGCGGACGGTCTTCGACGACGAGGCCGTGCACGCCTGCCTCGGCCTCGACGGGGAGGAGGAGAACGCGTGGGCGGCGGTGACGCTCGGACCGTACCTCCCGTACAGGGCGGACACCGGCGGACCCGACGCCCCGCCCCGCCCCGCCCTGCTGGAGCGCTCCCGGACGGTACGGCGCTCCGACCGCTTCACCGCCTTCCAGCGCGCGGCCCGCGAGGACACGAGCACCGCCGCGCCCGCCCGGCCGCCCGAGGACGCCGTACCGGCCACCGCGCCCGGCCCCGTGCCCGGGGACGCCGGACCGGCCGCCGCGCCCGGCCCCGTGCACGAGGACGCCGTGTCGGCCGCCGCGCCCCGCCCCGTGCCCGGGGACGCCGTGCCGGTCGGCCCGGTGCCGCTGCCCGCCCCCCGCGCCCTCGATCTCCTCGCCGCCGAGACCGCCGCGCGGCGGTTCTCGCGGGGGCGCTTGTTCACCGGGGCCGAGGCCGACGGGGAGGCCCTCGCGGGGGTGCTGGGGCAGGCGGCCGAGGCGCTGCGGGCGCTGGCCGGAGCCGGGGCGGACGGGCCGGCCGGGTGGGCCGCGCGGACCCGCCTGTACTGCGCCGTCCACCGGGTGCGCGGCGTGCCGCCGGGCTGGTACCGGTACGCGCACGAGCTGGGCGCGCTGCTGCCCGTGGGGGAGGGGACCGGGCCCGGCAGCGCGCGCCGGGTGCAGGAGGCGCTGTTCGCCGCCTCTTTCAACGCCGAGCTGGCCGCCTTCACCGTCCACCCGGTGACCCCGGCCGACTGGCGGCCGGCGGGCGGCCCGCGCGCCTACCGCGCGCAGCAGCTCGCCGTGGGCGCGGCGATCGAGGCGGTGACGCTGGCCGCGGCCGCCGAGGGCCTCAGCGGCCACGCCGTCCTCGGGTTCGACGTGACCCGGATCGACACGGCGTACGGCCTCGACGGCGGCGCGGACACGGACGGCGGGACCCAGGCGCAGATCTGCGTCGGCGCCGTACGCCCCGACCCGAACTGGGAGATTGCGGTGATGCCACGGTGA	MTMTTDEAYTYTTGLRLDPRSANPDGWRVDWADGPWPVKVYSGARRLPLRPDGPPPLAALHRLLHGGFAVSRIRTDPSGGIAATPADPRPHHGPEVQLRRPVPSGGAMYPTEVYAALTATGQVCHYDPYRHELTVLAGGDAAARLRAALHLPTEAAPAAVLVLTSRFWKNFYKYGDFATRLGLVDAGVALGRAARLARAEWEHAEVRTVFDDEAVHACLGLDGEEENAWAAVTLGPYLPYRADTGGPDAPPRPALLERSRTVRRSDRFTAFQRAAREDTSTAAPARPPEDAVPATAPGPVPGDAGPAAAPGPVHEDAVSAAAPRPVPGDAVPVGPVPLPAPRALDLLAAETAARRFSRGRLFTGAEADGEALAGVLGQAAEALRALAGAGADGPAGWAARTRLYCAVHRVRGVPPGWYRYAHELGALLPVGEGTGPGSARRVQEALFAASFNAELAAFTVHPVTPADWRPAGGPRAYRAQQLAVGAAIEAVTLAAAAEGLSGHAVLGFDVTRIDTAYGLDGGADTDGGTQAQICVGAVRPDPNWEIAVMPR	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNPAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	188.05	gnl|BL_ORD_ID|3655|hsp_num:0	4724			378	600	
BGC0000610.1|Nosiheptide_10 # 10830 # 12800 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.758	BGC0000610.1|Nosiheptide_10 	10830	12800	-	Loose	400	27.335	IMP-11	31.71	3002202	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGAGTACGGCGACCACCCCGCAGCCCCGCACCGGGCCGGCCGGGCCGCCGGTCGTCGTCGGGCGGGGCGTGCTCGCCGAGCATCTGGTCCGGCGCCTCGGCCGCGACGACACCCCCGACCCGGACGGCGGTGCACGCTTCGGCCGGTCCTCCGGGGCGACCGTGCTCGTCGCCGGGCTCGACGGGCTCGGCGAGTTCCAGGACACCGTCGTCGACTGCCTGGCCACCGGACGCTCCCTGCTCTTCGTCGGCAGCTGGCGCTCGCTCGTCTACATCGGCCCCGTCTGGCGCCCCGGCACCCAGGGCTGCCCGCGCTGCCTGGTGACCCGGACCGCCAACTCGCCCTTCGGGCCCGGCCTGGAGGGCGACAGCCTCGCCGAGTCCTGGCCGCACGGCGCGGACGTCCGCATCTGGGGACCCGGCGTGCTGCGGCTGGTCGAGGAGTACGTCCGCGCCCGGCTCGCGTCCTGCAAGGGCCCGGCCGGCCCGGCCGACGGCCGCGTCCTCGTCCTCGACGGCGCCGCCGGCACGGTCGAGCAGCAGACCCTGCTGCCGGACTCCGGCTGCCCGAACTGCGGCAGCCTCCGCGAGGACACCGTGCCCGCGCTGACCCCCGCCGCCGTCCCGCTCACCAAGCTCACCCCGGCCACCCTGCGCACCGGACGGCTGCCCGCGGACGCCGTCCGCGGCGACTACCTCTACGCCGGCCTCGGCCTGTTCAAGGAGCTGCGGCAGGACCTGCAGAGCCCCTTCGGGGCCTGCTCGGTGGAGCTGCCGCCGCGCTGGGGCCGCCGCGAGCCCGCCATCGGCCGCGCCGCCGACTACGCCACCAGCCGCACCGTCGCCGTCCTGGAGGGCCTGGAGCGCTACGCCGGCCTGCACCGCGGCGGCACCCTGCCCCCCGTGCGGGCCCGCTACGCGGACGTGGCCGACCAGGCCCTGTACCCGCCGGACCTGGGCACCCACCCGGAGGAGAGCTACGCCTCCGAAGGCTTCCGGTACCGGCCCTTCGACCCCGGCACCGAGATCGACTGGGTGGGCGCGTACTCCTTCCGCCGCGACGGACGCGTCCTCGTCCCGGAGCGCGCCGCGTTCTGGGGACCGCGCCACGACGACGAGATCTCCTTCTTCTACGACACCTCGAACGGCTGCGCCCTCGGCAACAGCGTCGAGGAGGCCGTCCTGCACGGCCTGCGCGAACTCGCCGAGCGGGACGCCTTCCTGCTCACCTGGTACCGCGAACTCGACGTCCCAGAGGTCGCCCTCGACGGCACCTCGCCCGCCCTGGACCACCTGCTGGCCAAGTCCCGCCTCTTCACCGGCTTCGACTTCCGCTGCTTCGACGCCACGATGGAGTACGGCGTCCCGGCGCTGCTGCTCACCGCCGAGAACGACAGCGGCGACGGGCCCCGGCTCTTCGCGGGCTGCGGCGCGCACCCCGACCCCGTCCAGGCCGTCACCGGCGCCCTGCACGAGCTGGTGGGCACGGTCCTCGCCACCCGGGACGCCTACGAGCGCCGCCGCCCCGACGCGCTGCGCATGCTGGCCGACCCGTTCCTCATCCGCCGCATGGAGGACCACTCCACGGTCGGCGCGCTGCCCGAGGCCCGCGACCGCTTCTCCTTCCTCCTCGACCGGCCCCGCACCGGCGCCCCCGTCCCGCTCGGCCGGGTCCGCTCGACGCTCCGCACGCAGGACGCCGACCTGCGGGCCGACCTGTACGCGGCCGTCTCCGGCGTCCTCGACTGCGGCCTCGACGTCCTGGTCGTCGACCAGACCATGCCCGAGCTGCGCCGCAACGGCCTGCACTGCGTCCGGGTGCTGGTGCCGGGCCTGATCCCGATGACCTTCGGCCACCGCAACCGCCGTACCTGCGGCCTGCCCCGGCTCACGGAGGGCACCACCCTGCCCTACCGCAGCCTGCTGGCCCCCGGCCGGGAGATCGGCGCCGTCCCGCACCCCTTCCCGTAG	MSTATTPQPRTGPAGPPVVVGRGVLAEHLVRRLGRDDTPDPDGGARFGRSSGATVLVAGLDGLGEFQDTVVDCLATGRSLLFVGSWRSLVYIGPVWRPGTQGCPRCLVTRTANSPFGPGLEGDSLAESWPHGADVRIWGPGVLRLVEEYVRARLASCKGPAGPADGRVLVLDGAAGTVEQQTLLPDSGCPNCGSLREDTVPALTPAAVPLTKLTPATLRTGRLPADAVRGDYLYAGLGLFKELRQDLQSPFGACSVELPPRWGRREPAIGRAADYATSRTVAVLEGLERYAGLHRGGTLPPVRARYADVADQALYPPDLGTHPEESYASEGFRYRPFDPGTEIDWVGAYSFRRDGRVLVPERAAFWGPRHDDEISFFYDTSNGCALGNSVEEAVLHGLRELAERDAFLLTWYRELDVPEVALDGTSPALDHLLAKSRLFTGFDFRCFDATMEYGVPALLLTAENDSGDGPRLFAGCGAHPDPVQAVTGALHELVGTVLATRDAYERRRPDALRMLADPFLIRRMEDHSTVGALPEARDRFSFLLDRPRTGAPVPLGRVRSTLRTQDADLRADLYAAVSGVLDCGLDVLVVDQTMPELRRNGLHCVRVLVPGLIPMTFGHRNRRTCGLPRLTEGTTLPYRSLLAPGREIGAVPHPFP	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	267.76	gnl|BL_ORD_ID|675|hsp_num:0	731			537	633	
BGC0000610.1|Nosiheptide_11 # 12797 # 14761 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.783	BGC0000610.1|Nosiheptide_11 	12797	14761	-	Loose	275	29.6462	AAC(6')-32	36.67	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACAGACGTGGCAGCAGACAGGGCACAGCCGGCCGGCCCGGCCGCCGACCCGCTGACCGACACCCTCACCCGCACCTACCGGCTCCGCGCCGACGCCTTCTACGTCCGCCAGCAGGACGGCGTCTGGCTCGGCAACAACACCGGCTCCTTCTCCGTCCGCGGCCAGGGCGCCTACCAGCTGGTCAGCTCCCTCTTCGCCGGGCTGGACGGCGAACGCACCCTCCAGGACCTCTACGGCGACCTGCCCGACCGGGCCCGCCGGTCCGTGCTGGGGCTGGTGCGGGCCATGCTGCGCAACGGCTTCATCAAGGAGGTCGCCCACCCCGTCGAGCCGGTGCCCGGCTGGATGCGCGAGCGGTACGCCACCCATCTGGCGTTCCTCGAACACCACGCCGACCGCCCGGTCACCCGCCTCCAGCAGGTCCGCACGGCACGCGTGGTGTGCGCGGGCCGCGGCACCGCGCTGCACGCCCTGCTGGACGCGCTGCGCGAGTTCGGCATCGCCCGGCTCGACGTGGTCCCGGACGGCGACGACGACCTGACCGCCGTACAGCAGGTGCTGAAGGAGACCGCCGCGGCGGATCCCGGGGCGCGCTGGCGGCTGCGCGACCCGCTCGCGGCGGACGGACCGGCCGCGCTGGCCGGACACCCCGACGTCGAGGGCGCCGACGCCGTCCTGCTCGCCTACGACAGCGCCGACGCCGCCGCGCTGGCCCGCTCCCAGCACGCGCTGTGGCGCGACGGTGTGACCGTCGGGGTCCTCGCCCGGTGCGGCGACTTCGTCACCGCGCTCGAACCCGGGCTGGGCACCCCGTACTGCTGGGAGTGCGTGCACCGCTCGATCGCCGTCCGGGCCACCGGCGACACCGCGGGCCTCGCCCCGGCGGTCGCCCCGGCCGCGGTCGGCGCGCTGCGGGTCGCGCAGCACACCTTCGCCCGGCTGGCCGGGGTCCGGCCGCCCGGGGACAAGCCGGTGACCACCGTCGAACCCCTCGTCCCCGCGGTGCGCGGCCACGCCGCCCGGCGGCACCCGCGCTGCCCGCACCACGAGCCCGCCGTACCGCGGCGGCTGCCGCCCGCCGGGGCCGCCGCACCCGAGGACGCCGTGCGGCCCGACATCCCGCGCTCCGAGGACCCGCCCGAGCGGGTGCGGATCTCCGACCGGATCGTGGCGGCCTGCGCCGCCCTGACGGACGCGGTCACCGGCCCGCTGCTCGCGCTCGGCGAGGAGGACCTGGCCCAGCTGCCGCTGTCGGCCAGTGCCTGCCAGGTCGCCGACCCGGACGGCGGCGCCGACGCGCCCGCCGCCCTCGGCGTGGTGTGCCGGGCGCTGTCCCCGCGCGAGGCCCGCAACCAGGTCGTGCTGTGCGCGGTGGAGTCGCTGGCCGGCCGCCTCACCGCAGGGGACGCGCGCTACGGCGCGGTCGGCGCCGGCTGGTCCCTGGGCGAGGCCCGGCTGCGCGCCCGGCTGCACGCGGCGCTCGGCCGGCCCACGCCGGACCTCCACTGGGCTCCGGCGCCGGAGGAGCCGCCGCCCGGCGACACCGCGGCAGGCTACCTCGCCGGGGTGCTGGCCGCCGAGGGCACGCCCTGGACCGCCACCGCCGCCGAGGAGCTGCCCGACGGCGTCGTCCGCGCCCATGTGCGCACCCGCGACGGCGCGGTCACCGCGGGCGTGGGCACCGACCGGGAACGGGCGGTGGGACACGCCCTCCTCAACGCGGTGGCGCGCGTCCTGCCGCTGCCCGGGAACGCCCAGGAGGCCACCGCCTTCCTGGCCCCGGCCACCGCGACCTGGACCGCCGCGCCCACCGCCGAAGGCGAACGCGAGATCACCGACCTGCTGCCCTTCCTCACCGACACCGACACCGGCACCGGCACCGGCACCGGCACCGGCAGCGGGGGAGAGGCCGGTGCCCGCGTCCGCGTCGTGGCCCTGCCCGTGTCCGAGGAGGCGTCATGA	MTDVAADRAQPAGPAADPLTDTLTRTYRLRADAFYVRQQDGVWLGNNTGSFSVRGQGAYQLVSSLFAGLDGERTLQDLYGDLPDRARRSVLGLVRAMLRNGFIKEVAHPVEPVPGWMRERYATHLAFLEHHADRPVTRLQQVRTARVVCAGRGTALHALLDALREFGIARLDVVPDGDDDLTAVQQVLKETAAADPGARWRLRDPLAADGPAALAGHPDVEGADAVLLAYDSADAAALARSQHALWRDGVTVGVLARCGDFVTALEPGLGTPYCWECVHRSIAVRATGDTAGLAPAVAPAAVGALRVAQHTFARLAGVRPPGDKPVTTVEPLVPAVRGHAARRHPRCPHHEPAVPRRLPPAGAAAPEDAVRPDIPRSEDPPERVRISDRIVAACAALTDAVTGPLLALGEEDLAQLPLSASACQVADPDGGADAPAALGVVCRALSPREARNQVVLCAVESLAGRLTAGDARYGAVGAGWSLGEARLRARLHAALGRPTPDLHWAPAPEEPPPGDTAAGYLAGVLAAEGTPWTATAAEELPDGVVRAHVRTRDGAVTAGVGTDRERAVGHALLNAVARVLPLPGNAQEATAFLAPATATWTAAPTAEGEREITDLLPFLTDTDTGTGTGTGTGSGGEAGARVRVVALPVSEEAS	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	355.43	gnl|BL_ORD_ID|1443|hsp_num:0	1577			60	237	amikacin; tobramycin; gentamicin
BGC0000610.1|Nosiheptide_12 # 14763 # 16088 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.766	BGC0000610.1|Nosiheptide_12 	14763	16088	-	Loose	200	29.261	vanX gene in vanF cluster	32.58	3002952	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGGGCCGACCAGCGTTCCAGCGCTTCCTGACCCCCCGTCACCTCCCGGCGGGCCGGGCCGGTGCCGTGACCGGCGTCCGCTGGGGCGGCGACTTCGCCGCCTGGGACGACCTGCTCACCGCCGGCCGCGACCTGGCCGCGCAGGTGCGTCCCGGCGGCGCGTACGCGATCGACCCCACCGCCGGACTCCCCGCGCTGGCCGCGCTGTTCGCCGTGGCCACCGTGCCGGACACGGTCCTGCTCTGGGCGTCGCCGCGCACCCTCGGCGTCACCGGGCGGGAGATCGCCCCGGCGCTGCACGCCCTCCCGGACGACGGGTCCGTACCGCTCGCGGCACAGGAGCGCCCGCTGTGGGGCGTGTGCACCTCCGGCAGCTCCGGCGCGCCCAAGGTGGCCGTCGGCCCCGCCGACGAGTGGGAGCAGATCGCCCTGCACGCCGAGGCGGCGATGTACGCGGACGCGTTCCCCGCGGGCCCGCCCGAGGCGCTGGCCACCTGTCTGCCGCTGGGGTTCTCCGCCGCGTTCTTCATGTGCGTCCTGCCCGCCCTCTACCTGAAACGGGACCTGGTCGTGCACCCGCCGCACGACTGGAGCCCGCTGTACGACCTCGCCCGCGACCGGCGCGTGCTGGCCCTCGGCGTCCCGGCCCTGGCCGCGGCGGCCTGCCTGTCCGCGCCCGCCGCCACCGACCTCGGCTCCGTCGCCCTGTTCCTCGGCGGCGGCCACCTCAGCGCCCCGCGGGTCGAGCTGATCCGCCGCCACTTCACCGGCGCCGCCGTCAGCAACCTGTACGGCACCGCCGAGACCGGCGCCATCGCCCTCGACCACGACCCCGGCCACAACCGGCACGTCGGCCGGCCGATCCCCGGCAAGTCCGTGTGGCTGACCGGCACCGACGAACGCGGCATCGGCACGGTCGCCGTCGCCGGCCCCGGCTGCTGCCGGCGCACCTGGCGGCCCGGCAGCCCGCCCTCCGCCCCCGCCGACCACGTGACCGGCACCGACTACGGCCGCTTCGACGCCGACGGCAACCTCTGCCTCGAAGGCCGCCTCGACGGCGCCGAGAAGCTCGCCGGAGTGCTCGTACGGCCCCGGGAGATCGAGCGCCACGTCCTCGCGCTCGACGGGGTCAGCGACGTACGGGTCACCGTCGAGACCGCCCCGACCGGCCTGGAGTTCCTGGCCGCCACGGTGGTCGGCAGCGTCGACGCGGACACCGTCCGCGCGCACTGCGCCGCCCTCCCCGAACAGCACCGGCCCAGCCGGATCAGCTGCGCCTCCGAGCAGGAGGCCGCAACCGTCTACAGCGCGCACGGGAAGCTCTGA	MGRPAFQRFLTPRHLPAGRAGAVTGVRWGGDFAAWDDLLTAGRDLAAQVRPGGAYAIDPTAGLPALAALFAVATVPDTVLLWASPRTLGVTGREIAPALHALPDDGSVPLAAQERPLWGVCTSGSSGAPKVAVGPADEWEQIALHAEAAMYADAFPAGPPEALATCLPLGFSAAFFMCVLPALYLKRDLVVHPPHDWSPLYDLARDRRVLALGVPALAAAACLSAPAATDLGSVALFLGGGHLSAPRVELIRRHFTGAAVSNLYGTAETGAIALDHDPGHNRHVGRPIPGKSVWLTGTDERGIGTVAVAGPGCCRRTWRPGSPPSAPADHVTGTDYGRFDADGNLCLEGRLDGAEKLAGVLVRPREIERHVLALDGVSDVRVTVETAPTGLEFLAATVVGSVDADTVRAHCAALPEQHRPSRISCASEQEAATVYSAHGKL	MEKDFVFLDEILHGVRWDSKYATWDNFTGKPVDGYEVNRIAGTYALAVALLEVKKQAAALGYGLLLWDGYRPQRAVNCFLHWSAQPEDGRTKERYYPNIDRIEMVTKGYVASKSSHSRGSAIDLTLYRLDTGALVPMGSGFDFMDERSHHTSKGISSNEAQNRQLLCSIMEYSGFESYVYEWWHYVLRNEPYPSSYFDFPIGGNHLDPFSNFCGTVPLDALSP	197.76	gnl|BL_ORD_ID|1499|hsp_num:0	1509			39	267	vancomycin
BGC0000610.1|Nosiheptide_13 # 16058 # 16297 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000610.1|Nosiheptide_13 	16058	16297	-	Loose	850	25.409	OpmH	33.33	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACATCTCAGCGCACCACACCCCGGACGCCGGACGGCGTACCGGACCTGCAGGAGGAGCTGGCCGGGCTGCTCCAGGAGGACGACCCGCGGCGGCGGCTCGACTCGCTGGAGACGGTCGTCGTCCTGTCGTACTTCGCCCGGCAGGCACCCGGGCGGACCCTGCCCGAACTGCCCGACGCGCCGCGCACGATCGAGGGGTGGGTGACATGGGCCGACCAGCGTTCCAGCGCTTCCTGA	MTSQRTTPRTPDGVPDLQEELAGLLQEDDPRRRLDSLETVVVLSYFARQAPGRTLPELPDAPRTIEGWVTWADQRSSAS	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	16.39	gnl|BL_ORD_ID|2005|hsp_num:0	2195			621	756	triclosan
BGC0000610.1|Nosiheptide_14 # 16294 # 17088 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=CGGAG;rbs_spacer=6bp;gc_cont=0.750	BGC0000610.1|Nosiheptide_14 	16294	17088	-	Loose	700	25.7942	gimA	25.45	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGGACACCGAGACGCCGAGGGACACGGAGACGCCGATGCACACCGGGATGTCGACGGGCCCGGAGACGCCCACCGTCTACCTGGTGCACGGGCTGCTGGGCACCGGCCACGGGCACTTCGCCGCGCAGATCCGGGCCTGGCACGGCCGGCTGCGGACCGTACCCGTGGATCTGCCCGGTCACGGCCGCTGCCGCCGTGACGCCGCCGAGGACTACTTCGACGACGCGCTGCGCTACCTCGTCGCCGTGCTGGAACGCTTCGGGCCCGGCCGGCTGATCGGCGCCTCCTACCTGGGAGGGCCGCTCGCCCACCGCTGCGCGGCCACCCGGCCCGACCTGGTCTCCTCGCTGGTGCTGACCGGGTTCGCGCCGGACGTCTCCCGCGACGCGTTCCTCTCGCTGATCGCCGGTTTCGAGGGCCTCGCCGCGCAGCAGCCGGCCCTGGCCGCCGAGTACGAGCAGCTGCACGGCACCCGGTGGAAGCGGACGCTCGACGCGGTCACCGGGCATGTCGAGCGGGACTTCGAGCGGACCGCGCTGGTCCGCGCGGCGGACGTGGCCGCGCTCACCGTCCCGACGCTCGTCCTCAACGGCTCCCTGAAGTCCGTCGAACGCGCGGCGGCCGAGCAGGCGCCCGGCTGGGGCGGCCGGGTCCGCGGCCGGGTCGTCCCCGGCGCCGGCCATCTGGTCGGCCACGACCGGCCGCGGGAGTTCAACGAGGCGGTCGAGGACTTCTGGCGCACCGCGCACGACGCACCCGCCGGTCCCCGAACGACGCAGAAGGGCGACACGTGA	MDTETPRDTETPMHTGMSTGPETPTVYLVHGLLGTGHGHFAAQIRAWHGRLRTVPVDLPGHGRCRRDAAEDYFDDALRYLVAVLERFGPGRLIGASYLGGPLAHRCAATRPDLVSSLVLTGFAPDVSRDAFLSLIAGFEGLAAQQPALAAEYEQLHGTRWKRTLDAVTGHVERDFERTALVRAADVAALTVPTLVLNGSLKSVERAAAEQAPGWGGRVRGRVVPGAGHLVGHDRPREFNEAVEDFWRTAHDAPAGPRTTQKGDT	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	63.31	gnl|BL_ORD_ID|1924|hsp_num:0	1994			153	483	tylosin; oleandomycin; chalcomycin; methymycin
BGC0000610.1|Nosiheptide_15 # 17114 # 18439 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.703	BGC0000610.1|Nosiheptide_15 	17114	18439	-	Loose	800	34.2686	Staphylococcus aureus LmrS	27.2	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAATGCGCAGGTGGGGAGGGTAACGGAGAAAGAGTGCTCCGTTTCCTCGGTGTCTTGTTCGGAATTCCCGGGTGGCGTTACATGGGCCGGGTCCCTTCCGGCCGTTCGCAGAGGAATTCACATGACGCAGAACTCCCAGGCAATGACCTCGCACGCAATGACCGGTGACTTCGTCCTGCCGGAGCTGGAGGACGTACGCGCCGAGGCGGCCACGGTGGACACCCGTGCCGTCCTCGCCCTCGCCGAGGGCGAGGAGCCGGCCGAGTCGCGGGCGGCGGTCGCGCTCGCCCTGTGGGAGGACCGCTCGATCGGCACCGCCGAGCTGCAGGCGGCCGCGGAGGCCCGGTGCGGGGCCCGCCGCCCCCGGCTGCACACCTTCGTGCCGCTCTACACCACCAACTACTGCGACTCCGAGTGCAAGATGTGCTCCATGCGGAAGGGCAACCACCGCCTCGACCGCAAGTTCTCCGGCCGCAAGGAGATCACCGAGCAGCTGGAGATCCTCTACCACCACGAGGGCGTCCGCGGGGTCGGCTTCCTCACCGGCGAGTACGAGGACAAGCACACCCGGCTCGCCTCCGCCTTCCGGATCGGCTGGGCCATCCGCACCGCCCTGGACCTGGGCTTCGAGCGGGTCTACTTCAACATCGGCAGCATGGAGCAGGACGAGATCGACGTCCTCGGCGAGTGGATCGGCCGGGAGGACCCGGTCACCATGTGCGTGTTCCAGGAGAGCTACGACCGCGAGACGTACCGCCGCTTCATGGGCAAGACCTCCGTCGGGGTGCCCAAGGCCGACTTCGACCGCCGGGTGGTCTCCTTCGACCGCTGGCTGGACGCCGGCTACCGGTATGTGAACCCCGGGGTGCTGGTCGGGCTGCACGACGACCTCTCCGCCGAGCTGGTGAGCCTGGTCGCGCACGGCGACCACCTGCGCTCCCGGGGCGCGACCGCCGACCTGTCGGTGCCGCGGATGCGGCCGGCCATGAAGTCCCGGGACACCACGCGGGTCGGCGACGACGACTACCTGCGGCTGATGTCGGTGGTCGCCTTCACCTGTCCCGAGCAGCGGCTCGTCCTCACCACGCGGGAGCCGCAGGAGTTCCAGGACGTCGCGCTGGGCCTGGCCGGCGTGATCTCGCCCGGCAGCCCCGACGTCGCCCCCTACCGGGCCGGCTGCGAGGCCCGCAACGACGAGAAGTCCTCCCAGTTCCTCGTCGCCGACCTGCGCCGGCCGCGGCACATCCTCGGCCGTATCGAGGCGTCCGGCACACCCGTCGACCACTTCGTGAACCCCGCGGGCGAGGCGTCCCGGGCGGTCTGA	MNAQVGRVTEKECSVSSVSCSEFPGGVTWAGSLPAVRRGIHMTQNSQAMTSHAMTGDFVLPELEDVRAEAATVDTRAVLALAEGEEPAESRAAVALALWEDRSIGTAELQAAAEARCGARRPRLHTFVPLYTTNYCDSECKMCSMRKGNHRLDRKFSGRKEITEQLEILYHHEGVRGVGFLTGEYEDKHTRLASAFRIGWAIRTALDLGFERVYFNIGSMEQDEIDVLGEWIGREDPVTMCVFQESYDRETYRRFMGKTSVGVPKADFDRRVVSFDRWLDAGYRYVNPGVLVGLHDDLSAELVSLVAHGDHLRSRGATADLSVPRMRPAMKSRDTTRVGDDDYLRLMSVVAFTCPEQRLVLTTREPQEFQDVALGLAGVISPGSPDVAPYRAGCEARNDEKSSQFLVADLRRPRHILGRIEASGTPVDHFVNPAGEASRAV	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	91.88	gnl|BL_ORD_ID|2869|hsp_num:0	3276			141	477	erythromycin; streptomycin; kanamycin A; linezolid; trimethoprim; chloramphenicol; florfenicol
BGC0000610.1|Nosiheptide_16 # 18492 # 18653 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.556	BGC0000610.1|Nosiheptide_16 	18492	18653	-	Loose	2000	23.0978	Staphylococcus aureus mupB conferring resistance to mupirocin	58.33	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGTCGACGGTAATTTACTTCGCGCATTTCCTGCAGCGCGTGCCTCGGAGGCTATGCAGCGGGTCTTCCGTGAGTCAAGGATTCCGGCCCTTTTGCATTTCTGCTGATTCCCCGCTGCTGTACTGCTGTGACGGCACAAAAAGGCCGCTAAAGCGCTGCTAA	MSTVIYFAHFLQRVPRRLCSGSSVSQGFRPFCISADSPLLYCCDGTKRPLKRC	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	5.13	gnl|BL_ORD_ID|4698|hsp_num:0	2271			1149	1185	mupirocin
BGC0000610.1|Nosiheptide_18 # 20075 # 21187 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=CGGAG;rbs_spacer=5bp;gc_cont=0.760	BGC0000610.1|Nosiheptide_18 	20075	21187	+	Loose	700	29.261	AQU-2	39.53	3004647	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	AQU beta-lactamase	GTGACCTCGGGACCGGGGCAGGCCCCGGCCGAGGCGGCACACGCAGCCGGGGCGGCCTGGCTGGAGATCGGGCTCGACGCCCCCGCCGACGCCGTACCCGCCCTGGTCGCCGGTGTCGTGCGGCCGCTGCTGCGGGAGCCCGCGGAGCCGGGGGCCGAGCCCGTGCCCGGGTTCTTCCTGCGGGGCGTCGGCGCGGCCCAGCCCGCCCTGGTCGTCCAGCTGGAGGTGACCCCCGGCACGGACCTCGCCGAGCCGTACGCCGCCCGGGCCCGCGCGCTCGCCGCCGGGCTGGGCCTCCCCGTGCAGGTCGCGGCCGGCCGGGCGACGCTCGTCCCGCTCGCCGGCTCGGTCTTCGCGGGGGCGGCCCTCGGCCCGGTGACCCGCGCCGCGCTGGCCGCCGTATGCCCCGCGCTGCTCACCGCCACCGAGGCCGCGGAACAGGGCAGGCCCGCCCTGCTGGCCAGTGCCGCCGAACTCATGTCCGCGCATCTGCGCGCGGTCAGCGTCTCCGCGGCCCCCGGCCCCCGCCAGTGGGAGGAACTGCGCGAGGGCGTGCCGCTCGGCTTCCTCAGCTACCGCTCGCACGCGGAGGCGTTCCTGGCCTCCAGCCGCGACCCGAAGGCCGCGCAGGCGATGATGGACGCGAAGTACACCCGCGCCGCGGCCACCCTGGAGCGCCTGGTCGACGGCGTCCTCACCCAGTGCGAGGAGCGCGGCCCGGTGGTCTCCCTGCCGGCGCGGCAGTGGTACGAGGCGATGCGCGCCGCCAAGCCCGCGGTGACCGAGCTGTTCCGCGCCGGAACCGACCTCGCCCTGGACACCGAGGAGCAGCCCCCGGACACCGGCCCGGACGGCAAGGGCCTGTCCGAAAGCGCGTTCCACCGCATTGTCGAGGGCTCCGACGGGCTGCGTGACTTCCTCGACCGCGACCCGTCCTTTCTGGCCACCCGACTGCTGACCAGCCTGCTCTACCTTTCCCTGAGCAGCGTCGGCATCGCCCTGGCGGAACGGTATTTCCTCTGCTACGCGGTGAGCCGCGCCTGTGAGTCGATCTTCGACACCGACGCCCTCACCGTCCTGTCCGGTCTGGCCCGGACCTCCCTGGCGTCCTGA	MTSGPGQAPAEAAHAAGAAWLEIGLDAPADAVPALVAGVVRPLLREPAEPGAEPVPGFFLRGVGAAQPALVVQLEVTPGTDLAEPYAARARALAAGLGLPVQVAAGRATLVPLAGSVFAGAALGPVTRAALAAVCPALLTATEAAEQGRPALLASAAELMSAHLRAVSVSAAPGPRQWEELREGVPLGFLSYRSHAEAFLASSRDPKAAQAMMDAKYTRAAATLERLVDGVLTQCEERGPVVSLPARQWYEAMRAAKPAVTELFRAGTDLALDTEEQPPDTGPDGKGLSESAFHRIVEGSDGLRDFLDRDPSFLATRLLTSLLYLSLSSVGIALAERYFLCYAVSRACESIFDTDALTVLSGLARTSLAS	MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVQANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSEQTLLAGNSAQVIMKANPTTAAPXEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHAILSKLAP	97.37	gnl|BL_ORD_ID|2125|hsp_num:0	3346			69	198	
BGC0000610.1|Nosiheptide_19 # 21653 # 22468 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.700	BGC0000610.1|Nosiheptide_19 	21653	22468	+	Loose	400	36.1946	vanR gene in vanI cluster	28.36	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGAGATCGATGTCCTGGGACCGCTTGAGGTCTCGCAGAAGTCCGCTTCGATTGTCCCGACGGCTTCCAAGCCGCGCACCGTCCTGGCGATGCTCGCCGTCTACACCAACCGGCTGGTCCCCCTGCCCTCCCTCATGGGAGAACTCTGGGGACCCGAACCGCCGGCCACCGCGAAGACGGCCGTACAGGGGTACATCCTGCATCTGCGCAAACGTATCGCCGAGTCCGCCGCGCGCCGCCCACCGGGCCAGTTCCCCGAGGCCAAGGACATCCTGGTCACCCTCCCCGGCGGCTATCTGCTGCGCGCCCCGGGAACCGCGGTGGTCCTGGAGCAGTTCGAGCAGCTGGCCTGCGCCGGACACCGCGCCCGGGAGAAGGGCGACTTCGAGGCCGCCTCGCGGAGCTTCACCGAGGCCCTCGGCCTGTGGCGCGGCCGCGCCCTCGCCGACGTTGAGGTGGGCCCCCAGCTGGGCATAGAGGTGCAGCGGATCGAGGAGGCCCGGCTCAACGTCCTCGACCGCAGGATCGAGGCCGACCTCCGGCTCGGCCGCCATCACGAACTCCTCGGTGAGCTGCGGAGCGTCACCGCCCACCACCCCACCCATGAGGGCTTCTGCGCCCACCTCATGCTGGCGCTCTACCGCTCCGGCCGCCGCTGCGAGGCACTCGACGCCTACCAGCGCATGCGCACCACGCTGGTGAACGAACTGGGACTGGAACCCTCCCCGTCCCTGCGCCGCCTCCAGCGCTCCCTGCTGGTCTCCGACCGCGAACTCGACGAACTCAACGTCACCTGGGACGTCGCCACGTTCTGA	MEIDVLGPLEVSQKSASIVPTASKPRTVLAMLAVYTNRLVPLPSLMGELWGPEPPATAKTAVQGYILHLRKRIAESAARRPPGQFPEAKDILVTLPGGYLLRAPGTAVVLEQFEQLACAGHRAREKGDFEAASRSFTEALGLWRGRALADVEVGPQLGIEVQRIEEARLNVLDRRIEADLRLGRHHELLGELRSVTAHHPTHEGFCAHLMLALYRSGRRCEALDAYQRMRTTLVNELGLEPSPSLRRLQRSLLVSDRELDELNVTWDVATF	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	116.81	gnl|BL_ORD_ID|2065|hsp_num:0	2246			450	642	vancomycin; teicoplanin
BGC0000610.1|Nosiheptide_21 # 26549 # 30076 # -1 # ID=1_21;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.666	BGC0000610.1|Nosiheptide_21 	26549	30076	-	Loose	2300	1805.03	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	75.68	3003283	protein variant model	D516G, H526T, L511R	I837V:5750	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GGTACGCGCGTAGTGAGTCCGAGCCCTCGGAAGGACCCCCTCTTGGCCGCCTCGCGCACTGCCTCGACCGCGAATACGAACAACGGCGCCAGCACCGCCCCGCTGCGCATCTCCTTTGCAAAGATCAAGGAGCCTCTCGAGGTTCCGAACCTGCTCGCGCTGCAGACCGAGAGCTTTGACTGGCTGCTCGGCAACACCGCCTGGCAGAGTCGGGTCGAGGAGGCTCTCGAGAACGGTCAGGACGTCCCCACCAAGTCCGGCCTCGAGGAGATCTTCGAGGAGATCTCCCCGATCGAGGACTTCTCGGGGTCGATGTCGCTGACCTTCCGCGACCACCGCTTCGAGCCGCCGAAGAACTCGATCGACGAGTGCAAGGAGCGCGACTTCACCTACGCCGCGCCGCTCTTCGTCACGGCCGAGTTCACCAACAACGAGACCGGCGAGATCAAGTCCCAGACCGTCTTCATGGGCGACTTCCCGCTCATGACGAACAAGGGCACGTTCGTCATCAACGGCACCGAGCGTGTCGTGGTGTCGCAGCTGGTCCGTTCCCCCGGTGTCTACTTCGACTCCAGCATCGACAAGACGTCCGACAAGGACATCTTCTCCGCCAAGATCATCCCGTCCCGGGGTGCCTGGCTGGAGATGGAGATCGACAAGCGCGACATGGTCGGTGTCCGCATCGACCGCAAGCGCAAGCAGTCCGTGACCGTCCTGCTCAAGGCGCTCGGCTGGACCACCGAGCAGATCCTCGAGGAGTTCGGCGAGTACGAGTCCATGCGCGCCACCCTGGAGAAGGACCACACCCAGGGCCAGGACGACGCGCTGCTCGACATCTACCGCAAGCTGCGCCCGGGCGAGCCCCCCACGCGTGAGGCCGCGCAGACGCTGCTGGAGAACCTCTACTTCAACCCCAAGCGCTACGACCTGGCCAAGGTCGGCCGCTACAAGGTCAACAAGAAGCTGGGCACGGACACCCCGCTGGACGCCGGGATCCTGACCGTCGAGGACATCATCGCGACGATCAAGTACCTGGTGAAGCTGCACGCCGGTGAGACCGAGACCGTCGGCGACAACGGCCAGCCGGTCGTCGTCGAGACCGACGACATCGACCACTTCGGCAACCGCCGCCTGCGCAGCGTCGGCGAGCTCATCCAGAACCAGGTCCGCACGGGTCTGGCCCGTATGGAGCGTGTCGTCCGCGAGCGGATGACGACCCAGGACGTCGAGGCGATCACGCCGCAGACCCTGATCAACATCCGGCCGGTCGTCGCCTCCATCAAGGAGTTCTTCGGCACCAGCCAGCTGTCCCAGTTCATGGACCAGAACAACCCGCTGTCCGGGCTGACGCACAAGCGTCGTCTGTCCGCGCTCGGCCCGGGTGGTCTCTCCCGTGAGCGGGCCGGCTTCGAGGTCCGTGACGTCCACCCGTCGCACTACGGCCGCATGTGCCCGATCGAGACCCCCGAAGGCCCGAACATCGGTCTGATCGGCTCGCTCGCCACCTACGGCCGCGTCAACGCGTTCGGCTTCGTCGAGACCCCGTACCGCAAGGTCGTCGACGGCCAGGTCACCGACGAGGTGAACTACCTGACCGCCGACGAGGAGGACCGCTTCGTCATCGCGCAGGCCAACGCGCCGCTCACCGCCGACATGCGGTTCGAGGAGGCCCGCGTCCTGGTCCGCCGCCGTGGCGGCGAGGTCGACTACGTCGCCCCCGAGGACGTGGACTACATGGACGTCTCGCCGCGCCAGATGGTGTCGGTCGCGACCGCCATGATCCCGTTCCTCGAGCACGACGACGCCAACCGTGCCCTCATGGGCGCGAACATGATGCGCCAGGCCGTGCCGCTGATTAAGTCCGAGGCCCCGCTCGTCGGCACCGGCATGGAGTACCGCTCCGCCGTCGACGCCGGCGACGTGGTCAAGGCCGAGAAGGACGGTGTGGTCCAGGAGGTCTCCGCGGACTACATCACCACCGCCAACGACGACGGCACGTACATCACGTACCGCCTGGCCAAGTTCTCCCGGTCCAACCAGGGCACCTCGGTCAACCAGAAGGTCATCGTCAACGAGGGCGACCGCGTCATCACGGGCCAGGTGCTCGCCGACGGCCCGGCCACCCAGAACGGCGAGATGGCGCTCGGCAAGAACCTGCTCGTGGCGTTCATGCCGTGGGAGGGTCACAACTACGAGGACGCGATCATCCTGTCGCAGCGCCTCGTGCAGGACGACGTCCTCTCCTCGATCCACATCGAGGAGCACGAGGTCGACGCCCGTGACACCAAGCTCGGCCCCGAGGAGATCACCCGGGACATCCCGAACGTCTCCGAGGAGGTCCTCGCCGACCTCGACGAGCGCGGCATCATCCGCATCGGTGCCGAGGTCATCGCCGGTGACATCCTCGTCGGCAAGGTCACGCCCAAGGGTGAGACCGAGCTGACGCCGGAGGAGCGCCTGCTGCGCGCCATCTTCGGTGAGAAGGCCCGTGAGGTCCGTGACACCTCGCTGAAGGTGCCGCACGGCGAGACCGGCAAGGTCATCGGTGTGCGCGTCTTCGACCGCGAGGAGGGCGACGAGCTGCCGCCGGGTGTGAACCAGCTGGTCCGCGTCTACGTCGCGCAGAAGCGCAAGATCACCGACGGTGACAAGCTCGCCGGCCGTCACGGCAACAAGGGTGTCATCTCCAAGATCCTGCCGATCGAGGACATGCCGTTCCTGGAGGACGGCACCCCGGTCGACATCATCCTCAACCCGCTGGGTGTGCCGTCCCGAATGAACCCGGGACAGGTCCTGGAGATCCACCTCGGCTGGCTCGCCAGCCGCGGCTGGGACGTCTCCGGCCTGGCGGACGAGTGGGCGCAGCGCCTCCAGGCGATCGGCGCCGACAAGGTCGAGCCCGGCACCAACGTCGCCACCCCGGTCTTCGACGGTGCGCGTGAGGACGAGCTCGCGGGTCTGCTGCAGCACACCATCCCGAACCGCGACGGCGAGCGCATGGTGCTCCCGTCCGGCAAGGCGCGACTGTTCGACGGCCGTAGCGGTGAGCCGTTCCCGGACCCGATCTCGGTCGGCTACATGTACATCCTGAAGCTGCACCACCTGGTCGACGACAAGCTGCACGCCCGCTCGACCGGTCCGTACTCGATGATCACCCAGCAGCCGCTGGGTGGTAAGGCCCAGTTCGGTGGCCAGCGCTTCGGTGAGATGGAGGTGTGGGCGCTGGAGGCGTACGGCGCCGCCTACGCCCTCCAGGAGCTGCTGACCATCAAGTCCGACGACGTCACCGGCCGCGTGAAGGTCTACGAGGCCATCGTCAAGGGCGAGAACATCCCTGAGCCCGGCATTCCCGAGTCCTTCAAGGTGCTCATCAAGGAAATGCAGTCCCTGTGCCTCAACGTGGAGGTGCTGTCCTCGGACGGCATGTCCATCGAGATGCGCGACACCGACGAGGACGTCTTCCGCGCTGCGGAGGAGCTCGGTATCGACCTGTCCCGGCGCGAGCCGAGCAGCGTCGAAGAGGTCTGA	GTRVVSPSPRKDPLLAASRTASTANTNNGASTAPLRISFAKIKEPLEVPNLLALQTESFDWLLGNTAWQSRVEEALENGQDVPTKSGLEEIFEEISPIEDFSGSMSLTFRDHRFEPPKNSIDECKERDFTYAAPLFVTAEFTNNETGEIKSQTVFMGDFPLMTNKGTFVINGTERVVVSQLVRSPGVYFDSSIDKTSDKDIFSAKIIPSRGAWLEMEIDKRDMVGVRIDRKRKQSVTVLLKALGWTTEQILEEFGEYESMRATLEKDHTQGQDDALLDIYRKLRPGEPPTREAAQTLLENLYFNPKRYDLAKVGRYKVNKKLGTDTPLDAGILTVEDIIATIKYLVKLHAGETETVGDNGQPVVVETDDIDHFGNRRLRSVGELIQNQVRTGLARMERVVRERMTTQDVEAITPQTLINIRPVVASIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGFEVRDVHPSHYGRMCPIETPEGPNIGLIGSLATYGRVNAFGFVETPYRKVVDGQVTDEVNYLTADEEDRFVIAQANAPLTADMRFEEARVLVRRRGGEVDYVAPEDVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMMRQAVPLIKSEAPLVGTGMEYRSAVDAGDVVKAEKDGVVQEVSADYITTANDDGTYITYRLAKFSRSNQGTSVNQKVIVNEGDRVITGQVLADGPATQNGEMALGKNLLVAFMPWEGHNYEDAIILSQRLVQDDVLSSIHIEEHEVDARDTKLGPEEITRDIPNVSEEVLADLDERGIIRIGAEVIAGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGETGKVIGVRVFDREEGDELPPGVNQLVRVYVAQKRKITDGDKLAGRHGNKGVISKILPIEDMPFLEDGTPVDIILNPLGVPSRMNPGQVLEIHLGWLASRGWDVSGLADEWAQRLQAIGADKVEPGTNVATPVFDGAREDELAGLLQHTIPNRDGERMVLPSGKARLFDGRSGEPFPDPISVGYMYILKLHHLVDDKLHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYALQELLTIKSDDVTGRVKVYEAIVKGENIPEPGIPESFKVLIKEMQSLCLNVEVLSSDGMSIEMRDTDEDVFRAAEELGIDLSRREPSSVEEV	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	100.26	gnl|BL_ORD_ID|1957|hsp_num:0	1237			0	3513	rifampin; rifaximin; rifabutin; rifapentine
